CDIO - Cardio Diagnostics Holdings Inc. Common stock

Day	1m	10m	60m	PreMarket	Market	AfterHours	Gap
4.49 0.02 (0.56%)	---	---	---	---	0.02 (0.56%)	---	---

Cardio Diagnostics Holdings Inc is a medical technology company focused on developing and commercializing epigenetics-based clinical tests for cardiovascular diseases. The company offers three AI-powered solutions for the risk assessment, detection, management, and monitoring of coronary heart diseases. These solutions are Epi+Gen CHD, a symptomatic CHD risk assessment clinical blood test targeting CHD events; PrecisionCHD, an integrated epigenetic-genetic clinical blood test for the detection of coronary heart disease; and Actionable Clinical Intelligence, a platform coupled to the Epi+Gen CHD and PrecisionCHD tests that provide personalized insights by linking the epigenetic and genetic biomarkers evaluated by these tests to the drivers of coronary heart disease.

Category: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES

Market Period: Closed

Earnings & Ratios

Basic EPS:: -0.97
Diluted EPS:: -0.97
Basic P/E:: -4.6546
Diluted P/E:: -4.6546
RSI(14) 1m:: 51.85
VWAP:: 4.55
RVol:: 1.4054

Events

Period	Kind	Movement	Occurred At
1m	Price increase 1m	4.58 +0.08 (+1.67%)	Oct 15 15:55
1m	Price decrease 1m	4.5 -0.05 (-1.1%)	Oct 15 14:49
10m	Price decrease 10m	4.36 -0.14 (-3.04%)	Oct 15 14:41
1m	Price decrease 1m	4.34 -0.08 (-1.86%)	Oct 15 14:38
60m	Price increase 60m	4.6 +0.3 (+6.98%)	Oct 15 14:29